Altered myelin sphingolipid and glycerophospholipid profiles in Huntington disease
Journal of Huntington's Disease · 2026-11 · 15 (4) · 615-624
DOI: 10.1177/18796397261472539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Huntington's Disease, online erschienen am 04.08.2026. Verfasst von Michael G Friedrich und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Horizons, University of Wollongong, Wollongong, NSW, Australia. Hauptthemen laut MEDLINE: Huntington Disease, Sphingolipids, Myelin Sheath, Glycerophospholipids. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Huntington's disease (HD) is a fatal neurodegenerative disease caused by a CAG repeat expansion in the Huntingtin gene ( HTT ). While classically considered a disease of grey matter, recent imaging data have revealed presymptomatic abnormalities in white matter (WM) tracts. Here, we report lipid changes in glycerophospholipids and sphingolipids from enriched myelin extracts of three WM tracts (internal capsule (IC), dorsomedial prefrontal cortex (dmPFC), corpus callosum (CC)) of HD and control donors. We found no difference in total lipid concentration between HD and control myelin. However, changes were observed at the lipid class level for the CC and dmPFC, with a reduction in the proportion of Hexosylceramides in HD myelin. When lipids were examined at a species level, there was a shift towards shorter glycerophospholipid fatty acid chain length in HD for all three regions, most notably in phosphatidylethanolamine species. This coincides with previous data showing a reduction in fatty acyl chain lengths in sphingolipid species in the caudate of the same donor cohort and suggests a widespread impact of HD on fatty acid metabolism in the brain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Horizons, University of Wollongong, Wollongong, NSW, Australia.
- School of Medical, Indigenous and Health Sciences, University of Wollongong, Wollongong, NSW, Australia.
- School of Science, University of Wollongong, Wollongong, NSW, Australia.
- The Florey Institute, The University of Melbourne, Parkville, VIC, Australia.
- Department of Anatomical Pathology, Alfred Health and Florey Neuroscience, Parkville, VIC, Australia.
- School of Chemistry, The University of Melbourne, Parkville, VIC, Australia.
ORCID-Profile: Michael G Friedrich, Gabrielle R Phillips, Reuben Se Young, Jesse A Michael, Huaqi Su, Helena Targa Dias Anastacio, Gavin E Reid, Todd W Mitchell
Zitieren
APA
Friedrich, M. G., Phillips, G. R., Young, R. S., Cameron, S., Bale, L. K., Michael, J. A., Su, H., Targa Dias Anastacio, H., McLean, C. A., Reid, G. E., & Mitchell, T. W. (2026). Altered myelin sphingolipid and glycerophospholipid profiles in Huntington disease. Journal of Huntington's Disease, 15(4), 615-624. https://doi.org/10.1177/18796397261472539
Vancouver
Friedrich MG, Phillips GR, Young RS, Cameron S, Bale LK, Michael JA, et al. Altered myelin sphingolipid and glycerophospholipid profiles in Huntington disease. Journal of Huntington's Disease. 2026;15(4):615-624. doi:10.1177/18796397261472539
BibTeX
@article{Friedrich2026,
author = {Friedrich, Michael G and Phillips, Gabrielle R and Young, Reuben Se and Cameron, Sarah and Bale, Luke K and Michael, Jesse A and Su, Huaqi and Targa Dias Anastacio, Helena and McLean, Catriona A and Reid, Gavin E and Mitchell, Todd W},
title = {Altered myelin sphingolipid and glycerophospholipid profiles in Huntington disease},
journal = {Journal of Huntington's Disease},
year = {2026},
volume = {15},
number = {4},
pages = {615--624},
doi = {10.1177/18796397261472539}
}
EUVIMED